Smart Annual Summit 2022

01
Dec

2022

When

Nairobi

Kenya

Where

As Africa’s leading ICT solutions provider specializing in the provision of innovative biometric solutions for managing medical schemes, Smart Applications International is hosting the Smart Annual Summit.

Why Attend

Smart Annual Summit 2022

Knowledge-sharing sessions that accelerate and facilitate the continued building of a World of Convenience.

Grow

Learn the innovative biometric solutions & use of smart applications through sessions.

Experience

Founders & MDs from leading organizations like Kenya Healthcare Federation, Sevens Springs Hub Limited, & Smart Applications International will share insights.

Be inspired

Get ICT and biometric solutions guidelines from CEOs, MDs, and founders.

Similar Events

You May Like

(0)

21-26 September 2023

CANCER/EVOLUTION Summit 2023

(0)

21-26 September 2023

CANCER/EVOLUTION Summit 2023

The CANCER/EVOLUTION SUMMIT is the first virtual conference dedicated to metabolic, lifestyle, and nutritional therapies for cancer prevention and treatment. The summit will be held from September 21-26, 2023. The summit will feature presentations fr

Event Started

Virtual

Paid

Healthcare

(0)

25-25 September 2023

Emerging Immune Modulation Strategies

(0)

25-25 September 2023

Emerging Immune Modulation Strategies

The coronavirus pandemic ignited interest in learning more about immune responses to infections, their downstream effects, and how they can be modulated. It also gave rise to increased awareness of the role of immunity in diseases like cancer, neurod

Starts in 2 days

Hybrid

Paid

Washington, DC

Healthcare

(0)

25-25 September 2023

Strategies for Targeting Kinases

(0)

25-25 September 2023

Strategies for Targeting Kinases

There has been growing interest in targeting kinases such as JAK, TYK, IRAK, SIK, CDK, MEK, ERK, RTK, PLK, PI3K, ALK, MAPK, GSK, LRRK, and more for their role in neurodegeneration, inflammation, cancer, autoimmune, and other disorders. However, targe

Starts in 2 days

Hybrid

Paid

Washington, DC

Healthcare

(0)

25-28 September 2023

Discovery On Target 2023

(0)

25-28 September 2023

Discovery On Target 2023

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

Starts in 2 days

Hybrid

Paid

Boston

Healthcare

(0)

26-27 September 2023

Small Molecules Targeting RNA

(0)

26-27 September 2023

Small Molecules Targeting RNA

Starts in 3 days

Hybrid

Paid

Boston

Healthcare

(0)

26-27 September 2023

AI/ML-Enabled Drug Discovery – Part 1

(0)

26-27 September 2023

AI/ML-Enabled Drug Discovery – Part 1

Cambridge Healthtech Institute’s two-part conference on Artificial Intelligence (AI)/Machine Learning (ML)-Enabled Drug Discovery will highlight the increasing use of computational tools, AI modeling, algorithms, and data science for identifying nove

Starts in 3 days

Hybrid

Paid

Boston

Healthcare

(0)

26-27 September 2023

Proteomics-Driven Drug Discovery

(0)

26-27 September 2023

Proteomics-Driven Drug Discovery

While finding novel druggable targets and drug modalities for therapeutic intervention remains a top priority for the pharma/biotech industry, identifying and validating "good" targets and leads remains challenging. Cambridge Healthtech Institute’s c

Starts in 3 days

Hybrid

Paid

Boston

Healthcare

(0)

26-27 September 2023

GPCR-Based Drug Discovery

(0)

26-27 September 2023

GPCR-Based Drug Discovery

Cambridge Healthtech Institute's GPCR-Based Drug Discovery conference is now in its 18th year. G protein-coupled receptors (GPCRs), because of their central role in so many cellular processes, are still among the largest class of molecules modulated

Starts in 3 days

Hybrid

Paid

Boston

Healthcare

(0)

26-27 September 2023

Small Molecules for Cancer Targets – Part 1

(0)

26-27 September 2023

Small Molecules for Cancer Targets – Part 1

Small molecule-based therapeutic options against traditionally hard-to-drug intracellular oncology targets (like KRAS) are being discovered at a more rapid pace and a few have even reached the market in the past few years. Not only do small molecules

Starts in 3 days

Hybrid

Paid

Boston

Healthcare

(0)

26-27 September 2023

Antibodies Against Membrane Protein Targets – Part 1

(0)

26-27 September 2023

Antibodies Against Membrane Protein Targets – Part 1

As the industry increasingly shifts its attention to biologics, more attention is being paid to the prospect of developing biotherapeutics against membrane-bound targets. For these large target classes, biologics offer improved selectivity, an altern

Starts in 3 days

Hybrid

Paid

Boston

Healthcare